Tankyrase inhibition demonstrates anti-fibrotic effects in preclinical pulmonary fibrosis models
Shoshy Alam Brinch, Ida Johnsen, Lena Willmer, Ole Vidhammer Bjørnstad, Teresa Lucifora, Karl Martin Forbord, María Candamo-Lourido, Maureen Tania Meling, Ingrid Lofthus Morken, Martin Frank Strand, Danny David Jonigk, Patrick Zardo, Hans‐Gerd Fieguth, Christina Hesse, Mark Alexander Skarsfeldt, , Jo Waaler
This study shows that the TNKS inhibitor OM-153 reduces fibrosis markers and ECM expression in multiple preclinical IPF models by inhibiting WNT/β-catenin and YAP signaling.
bioRxiv · Nov 13, 2025 · PreprintCell Biology